Jason Eric Evans Sells 10,300 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) CEO Jason Eric Evans sold 10,300 shares of Surgery Partners stock in a transaction on Monday, March 13th. The stock was sold at an average price of $30.11, for a total value of $310,133.00. Following the completion of the transaction, the chief executive officer now owns 426,554 shares in the company, valued at $12,843,540.94. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Jason Eric Evans also recently made the following trade(s):

• On Wednesday, March 15th, Jason Eric Evans sold 99 shares of Surgery Partners stock. The stock was sold at an average price of $30.10, for a total value of $2,979.90.
• On Monday, February 27th, Jason Eric Evans sold 20,042 shares of Surgery Partners stock. The stock was sold at an average price of $33.53, for a total value of $672,008.26.
• On Monday, February 13th, Jason Eric Evans sold 5,884 shares of Surgery Partners stock. The stock was sold at an average price of $33.90, for a total value of $199,467.60.

Surgery Partners Stock Performance

SGRY opened at $32.18 on Friday. Surgery Partners, Inc. has a 1 year low of $20.46 and a 1 year high of $63.87. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.87 and a quick ratio of 1.72. The stock has a fifty day moving average price of $32.90 and a 200 day moving average price of $28.84.

Surgery Partners (NASDAQ:SGRY – Get Rating) last announced its quarterly earnings results on Wednesday, March 1st. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.06. Surgery Partners had a negative return on equity of 0.14% and a negative net margin of 2.15%. The company had revenue of $707.10 million during the quarter, compared to analysts’ expectations of $688.34 million. As a group, equities analysts expect that Surgery Partners, Inc. will post 0.4 EPS for the current year.

Institutional Trading of Surgery Partners

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. PNC Financial Services Group Inc. lifted its position in shares of Surgery Partners by 34.7% in the first quarter. PNC Financial Services Group Inc. now owns 1,195 shares of the company’s stock worth $66,000 after buying an additional 308 shares during the last quarter. Rockefeller Capital Management L.P. lifted its position in shares of Surgery Partners by 35.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,709 shares of the company’s stock worth $47,000 after buying an additional 449 shares during the last quarter. Metropolitan Life Insurance Co NY lifted its position in shares of Surgery Partners by 25.9% in the fourth quarter. Metropolitan Life Insurance Co NY now owns 3,025 shares of the company’s stock worth $84,000 after buying an additional 622 shares during the last quarter. Barclays PLC lifted its position in shares of Surgery Partners by 5.8% in the fourth quarter. Barclays PLC now owns 13,436 shares of the company’s stock worth $374,000 after buying an additional 735 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Surgery Partners by 139.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,379 shares of the company’s stock worth $32,000 after buying an additional 804 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on SGRY shares. SVB Leerink decreased their target price on Surgery Partners from $55.00 to $40.00 and set an “outperform” rating on the stock in a report on Tuesday, November 22nd. Stifel Nicolaus lowered their price target on Surgery Partners from $44.00 to $36.00 in a report on Tuesday, November 22nd. Citigroup lifted their price target on Surgery Partners from $38.00 to $40.00 in a report on Thursday, March 2nd. Barclays lowered their price target on Surgery Partners from $69.00 to $56.00 and set an “overweight” rating on the stock in a report on Wednesday, January 18th. Finally, Benchmark reiterated a “buy” rating and set a $47.00 price target on shares of Surgery Partners in a report on Monday, March 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $42.00.

About Surgery Partners

(Get Rating)

Surgery Partners, Inc is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services.